Found 5 matching trials
Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels
PHASE1This Study will first evaluate the safety and pharmacokinetics of a single ...
Location
Baptist Health Center for Clinical Research
A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II
PHASE3This is one of two replicate randomized, double-blind, placebo-controlled, ...
Location
Clinical Research Of West Florida Incorporated
A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA
PHASE1This Phase 1/2 study will evaluate the safety and pharmacodynamics (PD) of ...
Location
National Human Genome Research Institute, National Institutes of Health
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma
PHASE1Background:
Mesothelioma is cancer of the tissue that lines some organs. A...
Location
National Institutes of Health Clinical Center
Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid
PHASE2This is an open label multicenter study to evaluate the safety and tolerabi...
Location
Anaheim Clinical Trials